血清応答因子のトランスクリプションコファクターであるミオカルディンによる心臓遺伝子発現の活性化
1Department of Molecular Biology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390, USA.
Cell
|July 6, 2001
まとめ
科学者は,筋肉の遺伝子調節に不可欠な強力な転写因子であるミオカルディンを発見しました. ミオカルディンは血清応答因子 (SRF) と連携して,心臓の発達に不可欠な心臓筋遺伝子を活性化します.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
- 心血管生物学 心血管生物学
背景:
- 血清応答因子 (SRF) は,筋肉および成長因子誘導性遺伝子のレギュレータとして知られています.
- SRFの非特異的な性質は,筋肉遺伝子の活性化にミオジェニック付属因子の関与を示唆しています.
研究 の 目的:
- バイオインフォマティクスアプローチを用いて新しい心臓特異遺伝子を特定する.
- 新しく発見された転写因子,ミオカルディンと,筋肉の遺伝子調節におけるその役割の特徴を明らかにする.
主な方法:
- 心臓特異遺伝子の生物情報学に基づくスクリーニング.
- 心臓および滑らかな筋肉の細胞における表現分析.
- Xenopus胚における支配的陰性変異体を使った機能的研究.
主要な成果:
- 心臓および滑らかな筋肉で発現する強力な転写因子であるミオカルディンの識別.
- ミオカルディンはSRFと結合して,心筋プロモーターを活性化します.
- ミオカルディン機能の阻害は,Xenopusで心筋細胞の分化を妨害する.
結論:
- ミオカルディンは,SRFと協力する新しい筋肉転写因子です.
- ミオカルディンは,SRFが心筋特異的な遺伝子を調節するためのメカニズムを提供します.
- ミオカルディンは,心筋の発達と機能において重要な役割を果たします.
さらに関連する動画
関連する概念動画
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
General Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...


